The Role of Genetic Testing in Cancer Risk Management

Genetic testing has emerged as a crucial tool in managing cancer risk, particularly for hereditary cancers such as breast and ovarian cancer. Brooke Lane's experience illustrates this impact; after being diagnosed with stage 3 ovarian cancer at age 35, genetic testing revealed she carried the BRCA1 mutation, which also affected her mother, Sharon Shealy. This testing led to a preventive hysterectomy for Shealy, uncovering a hidden cancerous tumor that would have otherwise gone undetected. According to the National Cancer Institute, approximately 10-15% of ovarian cancers are hereditary, emphasizing the importance of genetic testing in identifying at-risk individuals.

Genetic Testing for Cancer Helps Patients Evaluate and Manage Their Risk FactorsUnderstanding Genetic Cancer Risk and TestingNatureAFRO News | The AFRO-American NewspapersEarly ctDNA Status May Guide Consolidation Immunotherapy for Limited-Stage SCLC

Genetic counseling plays a vital role in the testing process. Counselors assess family histories, explain potential test outcomes, and guide individuals on the implications of their results. Results can be categorized as positive (indicating a mutation), negative (no mutations found), or a variant of uncertain significance (VUS). Positive results can lead to increased surveillance or preventive measures, while negative results can alleviate anxiety about cancer risk. Dr. Hiral Shah from Zangmeister Cancer Center notes that while testing can induce stress, it ultimately empowers patients to make informed health decisions.

Genetic Testing for Cancer Helps Patients Evaluate and Manage Their Risk Factors

Genetic testing is increasingly accessible, with many facilities offering it without a physician referral. Costs vary, with self-pay rates around $250 at OhioHealth and similar institutions. However, insurance coverage can be inconsistent, which may limit access for some individuals. Programs like Ohio State's online family health risk calculator and Parkview Health's DNA Insights initiative aim to broaden access to genetic risk assessments and testing, enabling more individuals to understand their genetic predispositions.

Sept. 10 - Parkview expands DNA Insights program to the public

Despite the benefits, there are concerns regarding the emotional toll of genetic testing. Patients may experience anxiety about potential outcomes, and the implications of a positive result can be daunting. Additionally, disparities in access to genetic testing persist, particularly among minority populations. Research indicates that Black patients are less likely to be offered genetic testing, which can lead to gaps in understanding hereditary risks across diverse communities.

AFRO News | The AFRO-American Newspapers

The future of genetic testing in cancer risk management looks promising. As technology advances, the number of genes that can be tested is increasing, potentially leading to earlier detection and improved survival rates. Dr. Shah expresses hope that as genetic testing becomes more normalized, more individuals will take advantage of these assessments. Furthermore, initiatives like Parkview's DNA Insights aim to integrate genetic information into routine healthcare, fostering a proactive approach to cancer prevention and treatment.

Sept. 10 - Parkview expands DNA Insights program to the public

• “They would never have caught it if we hadn’t done the genetic testing. The genetic testing saved her.” — Brooke Lane, Cancer Survivor

Genetic Testing for Cancer Helps Patients Evaluate and Manage Their Risk Factors

• “It gives you a lot more information to make the best medical and lifestyle decision for yourself and for other family members,” — Dr. Hiral Shah, Oncologist

Genetic Testing for Cancer Helps Patients Evaluate and Manage Their Risk Factors

• “Integrating genetic information into everyday care is the future of medicine,” — Dr. Michael Mirro, Parkview Health

Sept. 10 - Parkview expands DNA Insights program to the public

• “Through genetic counseling, they can learn about the condition, discuss different paths forward and feel supported throughout the process. Regardless of the end decision, knowledge becomes a tool, not a burden.” — Natalie Sampson, Genetic Counselor

AFRO News | The AFRO-American Newspapers

In conclusion, genetic testing represents a significant advancement in cancer risk management, offering individuals the opportunity to make informed decisions about their health. As awareness and accessibility increase, the potential for early detection and personalized care continues to grow.

Genetic Testing for Cancer Helps Patients Evaluate and Manage Their Risk Factors